Please login to the form below

Not currently logged in
Email:
Password:

melanoma

This page shows the latest melanoma news and features for those working in and with pharma, biotech and healthcare.

EORTC and Pierre Fabre launch phase 3 trial for melanoma

EORTC and Pierre Fabre launch phase 3 trial for melanoma

Melanoma develops through unrepaired DNA damage to skin cells, which triggers mutations that can multiply and form malignant tumours. ... It is estimated that around 18% of stage 2B and 25% of stage 2C patients die from melanoma within ten years of

Latest news

More from news
Approximately 85 fully matching, plus 301 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 14 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....